Clinical Trial Matching

Selected news for Clinical Trial Matching, representing 18% of data collected since 1/2018. Recent stories appear in salvohaber.com and haberuygulamasi.com. This healthcare topic shares news with Anderson, Indiana, IBM Watson, American Society of Clinical Oncology and many others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
9/9/2020 Singapore launches first nationwide collaborative ecosystem for cancer care MobiHealthNews ... start-up Oncoshot has launched Project EISE (Enhanced Clinical Trial Initiation, Screening and Enrolment), the country’s first nationwide collaborative effort connecting cancer patients, healthcare professionals, as well as pharmaceutical and biotechnology companies via its clinical trial matching platform. The initiative serves as a bridge between its private and public sector partners, which include National Cancer Centre Singapore (NCCS), pharmaceutical giant Roche, cancer immunotherapy start-up CytoMed Therapeutics, as well as ...
9/1/2020 Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-ill COVID-19 Patients PR Newswire ... University of California, San Francisco and Silicon Valley entrepreneurs. Our mission is to integrate high-impact research with clinical processes and systems technology, resulting in improved data management and information systems, greater access to clinical trial matching and sponsorship, and greater benefit to providers, patients, and researchers. Quantum Leap provides operational, financial, and regulatory oversight to all I-SPY Trials. For more information, visit www.quantumleaphealth.org . About Razuprotafib (formerly known as ...
8/22/2020 Life Lessons From Lung Cancer ... wife to lung cancer. Life Lessons From Lung Cancer These are Ken’s answers to my questions about coping with end of life issues. We wished we had known about the Lung Cancer Alliance , their clinical trial matching services, and the resources they had available to bring order and some confidence that we were doing everything we needed to be doing. We were always left with the feeling, right to the ...
7/15/2020 Fight CRC Partners with Perthera to Deliver Precision Oncology to Cancer Patients Fight CRC is partnering with Perthera, the market leader in precision oncology to provide precision cancer care answers to patients from across the nation with colon and rectal cancers. This collaborative effort will deliver molecular profiling, personalized treatment recommendations, and clinical trial matching to patients with colorectal cancer. “We are excited to not only work with Fight CRC on this program, with staff and volunteers that have driven many successful ...
7/7/2020 Quantum Leap Healthcare Collaborative Announces the Selection of Byondis' SYD985 in the I-SPY 2 TRIAL for Stage 2/3, High-Risk Breast Cancer PR Newswire ... San Francisco and Silicon Valley entrepreneurs. Our mission is to integrate care and research, and to foster high-impact trials with embedded clinical processes and systems technology and improved data management, greater access to clinical trial matching , and greater benefit to patients, providers and researchers. Our goal is to improve and save lives. Quantum Leap provides operational, financial, and regulatory oversight to I-SPY. For more information, visit https://www.quantumleaphealth.org ...
7/7/2020 Intermountain Healthcare Implements DeepThink Health's Precision Intelligence Solutions to Manage its Molecular Tumor Board PR Newswire ... a specific patient to similar patients and analyze their outcome and prognosis within the institution or across broader evidence sharing networks. The solution enables evidence-based decision making for molecular testing, therapy selection, and clinical trial matching . It provides quality and compliance reporting, as well as outcome analytics to monitor consistency in care and value-based performance. "We are excited to partner with DeepThink as we continue to advance our ...
6/17/2020 MD Anderson and Philips collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers BioSpace HOUSTON and AMSTERDAM, Netherlands The University of Texas MD Anderson Cancer Center and Royal Philips today announced a collaboration to provide oncologists with evidence-based therapy and clinical trial guidance through Philips’ oncology informatics solutions and MD Anderson’s Precision Oncology Decision Support (PODS) system. This collaboration will allow physicians around the world to personalize therapy based on the patient’s genomic profile, with the aim of improving patient care. MD Anderson ...
6/16/2020 Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers Globe Newswire June 16, 2020 09:00 ET Source: Royal Philips Physicians discuss patient treatment options Oncology informatics provides actionable information to physicians June 16, 2020 Philips connects oncologists and pathologists around the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of actionable clinical information Amsterdam, the Netherlands, and Houston, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and The University of Texas MD Anderson Cancer ...
6/16/2020 Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers June 16, 2020 0 June 16, 2020 Philips connects oncologists and pathologists around the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of actionable clinical information Amsterdam, the Netherlands, and Houston, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and The University of Texas MD ...
6/16/2020 MD Anderson and Philips collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers Newswise Blog MD Anderson and Philips collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers Philips connects oncologists and pathologists around the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of actionable clinical information 16-Jun-2020 9:15 AM EDT , by University of Texas M. D. Anderson Cancer Center contact patient services Newswise — HOUSTON and AMSTERDAM, Netherlands ― The University of Texas MD Anderson ...
6/16/2020 Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers PRESS RELEASES Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers admin June 16, 2020 Philips connects oncologists and pathologists around the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of actionable clinical information Amsterdam, the Netherlands, and Houston, US – Royal ...
6/16/2020 Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers Press Releases Search for: Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers Jun 16, 2020 PRESS RELEASES Comments Off on Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers June 16, 2020 Philips connects oncologists and pathologists around the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of actionable ...
6/16/2020 Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers Posted by admin on in PRESS RELEASES 2 Views June 16, 2020 Philips connects oncologists and pathologists around the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of actionable clinical information Amsterdam, the Netherlands, and Houston, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and ...
6/16/2020 Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers 16 Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers Asianet Pakistan June 16, 2020 Philips connects oncologists and pathologists around the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of actionable clinical information Amsterdam, the Netherlands, and Houston, US – Royal ...
6/16/2020 Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers Philips and MD Anderson collaborate to facilitate personalized oncology treatments and clinical trial matching based on genomic markers Closed by admin June 16, 2020 Press Releases June 16, 2020 Philips connects oncologists and pathologists around the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of actionable clinical information Amsterdam, the Netherlands, and Houston, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and The ...